Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7)

Sabrine Douiyeb; Jara R. de la Court; Bram Tuinte; Ferdi Sombogaard; Rogier P. Schade; Marianne Kuijvenhoven; Tanca Minderhoud; Kim C. E. Sigaloff

doi:10.1007/s11096-022-01393-9

Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7)

Sabrine Douiyeb
, Jara R. de la Court
, Bram Tuinte
, Ferdi Sombogaard
, Rogier P. Schade
, Marianne Kuijvenhoven
, Tanca Minderhoud
, Kim C. E. Sigaloff

Research output: Contribution to journal › Comment/Letter to the editor › Academic

12 Downloads (Pure)

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Original language	English
Pages (from-to)	834-834
Number of pages	1
Journal	International journal of clinical pharmacy
Volume	44
Issue number	3
DOIs	https://doi.org/10.1007/s11096-022-01393-9
Publication status	Published - Jun 2022

Access to Document

10.1007/s11096-022-01393-9

Correction-to.pdfFinal published version, 297 KBLicence: CC BY

Fingerprint

Dive into the research topics of 'Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7)'. Together they form a unique fingerprint.

Cite this

Douiyeb, S., de la Court, J. R., Tuinte, B., Sombogaard, F., Schade, R. P., Kuijvenhoven, M., Minderhoud, T., & Sigaloff, K. C. E. (2022). Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7). International journal of clinical pharmacy, 44(3), 834-834. https://doi.org/10.1007/s11096-022-01393-9

Douiyeb, Sabrine ; de la Court, Jara R. ; Tuinte, Bram et al. / Correction to : Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7). In: International journal of clinical pharmacy. 2022 ; Vol. 44, No. 3. pp. 834-834.

@article{c85c6fd305d44d8c98bd6cccf8d17f0e,

title = "Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7)",

abstract = "An amendment to this paper has been published and can be accessed via a link at the top of the paper.",

author = "Sabrine Douiyeb and \{de la Court\}, \{Jara R.\} and Bram Tuinte and Ferdi Sombogaard and Schade, \{Rogier P.\} and Marianne Kuijvenhoven and Tanca Minderhoud and Sigaloff, \{Kim C. E.\}",

note = "Publisher Copyright: {\textcopyright} 2022, Springer Nature Switzerland AG.",

year = "2022",

month = jun,

doi = "10.1007/s11096-022-01393-9",

language = "English",

volume = "44",

pages = "834--834",

journal = "International journal of clinical pharmacy",

issn = "2210-7703",

publisher = "Springer Netherlands",

number = "3",

}

Douiyeb, S, de la Court, JR, Tuinte, B, Sombogaard, F, Schade, RP , Kuijvenhoven, M, Minderhoud, T & Sigaloff, KCE 2022, 'Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7)', International journal of clinical pharmacy, vol. 44, no. 3, pp. 834-834. https://doi.org/10.1007/s11096-022-01393-9

Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7). / Douiyeb, Sabrine; de la Court, Jara R.; Tuinte, Bram et al.
In: International journal of clinical pharmacy, Vol. 44, No. 3, 06.2022, p. 834-834.

Research output: Contribution to journal › Comment/Letter to the editor › Academic

TY - JOUR

T1 - Correction to

T2 - Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7)

AU - Douiyeb, Sabrine

AU - de la Court, Jara R.

AU - Tuinte, Bram

AU - Sombogaard, Ferdi

AU - Schade, Rogier P.

AU - Kuijvenhoven, Marianne

AU - Minderhoud, Tanca

AU - Sigaloff, Kim C. E.

PY - 2022/6

Y1 - 2022/6

N2 - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

AB - An amendment to this paper has been published and can be accessed via a link at the top of the paper.

UR - https://www.scopus.com/pages/publications/85128546022

U2 - 10.1007/s11096-022-01393-9

DO - 10.1007/s11096-022-01393-9

M3 - Comment/Letter to the editor

C2 - 35445999

SN - 2210-7703

VL - 44

SP - 834

EP - 834

JO - International journal of clinical pharmacy

JF - International journal of clinical pharmacy

IS - 3

ER -

Douiyeb S, de la Court JR, Tuinte B, Sombogaard F, Schade RP , Kuijvenhoven M et al. Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7). International journal of clinical pharmacy. 2022 Jun;44(3):834-834. doi: 10.1007/s11096-022-01393-9

Correction to: Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study (International Journal of Clinical Pharmacy, (2022), 44, 2, (557-563), 10.1007/s11096-022-01379-7)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this